Skip to main content
Premium Trial:

Request an Annual Quote

Women the World Over Rejoice

A new DNA test from Qiagen outperforms Pap smears in detecting the virus behind cervical cancer, reports the New York Times. An article in the New England Journal of Medicine looks into the effectiveness of human papillomavirus testing versus cytologic testing versus visual inspection of the cervix with acetic acid on of cervical cancer incidence and death in India. After eight years of follow-up, the authors report that a single round of HPV testing was associated with a decline in cervical cancer and death as compared to an uninspected control group, while the other groups showed no reduction as compared to the control. An NEJM editorial adds, "The implications of the findings of this trial are immediate and global: international experts in cervical-cancer prevention should now adapt HPV testing for widespread implementation." With funding from the Gates Foundation, Qiagen has developed a $5 version of the test.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.